Findings from the 2025 AMCP Foundation Symposium: Health Optimization 2.0.

IF 3.3 4区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Bridget Flavin, Steve Kheloussi
{"title":"Findings from the 2025 AMCP Foundation Symposium: Health Optimization 2.0.","authors":"Bridget Flavin, Steve Kheloussi","doi":"10.18553/jmcp.2026.32.7-a.s1","DOIUrl":null,"url":null,"abstract":"<p><p>The 2025 AMCP Foundation Symposium: Health Optimization 2.0 convened a select group of just over 70 managed care stakeholders in Dallas, Texas, on December 2-3, 2025. Via presentations and panel sessions, participants examined how precision medicine, data analytics, evolving policy, and health system design can address inequities in care delivery. Focus areas included precision medicine in oncology, vaccine hesitancy, use of data and artificial intelligence, and multiple sclerosis. Following group sessions, participants were divided into work groups and asked to highlight 1 key problem-solution pair for each of 2 assigned focus areas. This article presents a summary of the discussion for key problem-solution pairs in each of the 4 focus areas. The problem-solution pairs identified for vaccine hesitancy all related to delivering positive, community-driven messaging to rebuild eroded public trust. The other focus areas had multiple problems and solutions, which implies that driving meaningful change in these areas may be more complex.</p>","PeriodicalId":16170,"journal":{"name":"Journal of managed care & specialty pharmacy","volume":"32 7-a Suppl","pages":"S1-S10"},"PeriodicalIF":3.3000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13307509/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of managed care & specialty pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18553/jmcp.2026.32.7-a.s1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

The 2025 AMCP Foundation Symposium: Health Optimization 2.0 convened a select group of just over 70 managed care stakeholders in Dallas, Texas, on December 2-3, 2025. Via presentations and panel sessions, participants examined how precision medicine, data analytics, evolving policy, and health system design can address inequities in care delivery. Focus areas included precision medicine in oncology, vaccine hesitancy, use of data and artificial intelligence, and multiple sclerosis. Following group sessions, participants were divided into work groups and asked to highlight 1 key problem-solution pair for each of 2 assigned focus areas. This article presents a summary of the discussion for key problem-solution pairs in each of the 4 focus areas. The problem-solution pairs identified for vaccine hesitancy all related to delivering positive, community-driven messaging to rebuild eroded public trust. The other focus areas had multiple problems and solutions, which implies that driving meaningful change in these areas may be more complex.

2025年AMCP基金会研讨会:健康优化2.0的研究结果。
2025年12月2日至3日,AMCP基金会研讨会:健康优化2.0在德克萨斯州达拉斯召集了70多名管理式医疗利益相关者。通过演讲和小组讨论,与会者探讨了精准医疗、数据分析、不断发展的政策和卫生系统设计如何解决医疗服务中的不公平问题。重点领域包括肿瘤学的精准医学、疫苗犹豫、数据和人工智能的使用以及多发性硬化症。在小组会议之后,参与者被分成工作组,并被要求为两个指定的重点领域中的每个领域突出一个关键问题解决方案对。本文对这4个重点领域中的关键问题-解决方案对的讨论进行了总结。确定的疫苗犹豫问题-解决方案对都与提供社区驱动的积极信息有关,以重建受到侵蚀的公众信任。其他重点领域有多个问题和解决方案,这意味着在这些领域推动有意义的变革可能更加复杂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of managed care & specialty pharmacy
Journal of managed care & specialty pharmacy Health Professions-Pharmacy
CiteScore
3.50
自引率
4.80%
发文量
131
期刊介绍: JMCP welcomes research studies conducted outside of the United States that are relevant to our readership. Our audience is primarily concerned with designing policies of formulary coverage, health benefit design, and pharmaceutical programs that are based on evidence from large populations of people. Studies of pharmacist interventions conducted outside the United States that have already been extensively studied within the United States and studies of small sample sizes in non-managed care environments outside of the United States (e.g., hospitals or community pharmacies) are generally of low interest to our readership. However, studies of health outcomes and costs assessed in large populations that provide evidence for formulary coverage, health benefit design, and pharmaceutical programs are of high interest to JMCP’s readership.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书